Recent advances in the potential effects of natural products from traditional Chinese medicine against respiratory diseases targeting ferroptosis

Tian Chen,Lu Ding,Meiru Zhao,Siyu Song,Juan Hou,Xueyan Li,Min Li,Kai Yin,Xiangyan Li,Zeyu Wang
DOI: https://doi.org/10.1186/s13020-024-00918-w
IF: 4.546
2024-03-24
Chinese Medicine
Abstract:Respiratory diseases, marked by structural changes in the airways and lung tissues, can lead to reduced respiratory function and, in severe cases, respiratory failure. The side effects of current treatments, such as hormone therapy, drugs, and radiotherapy, highlight the need for new therapeutic strategies. Traditional Chinese Medicine (TCM) offers a promising alternative, leveraging its ability to target multiple pathways and mechanisms. Active compounds from Chinese herbs and other natural sources exhibit anti-inflammatory, antioxidant, antitumor, and immunomodulatory effects, making them valuable in preventing and treating respiratory conditions. Ferroptosis, a unique form of programmed cell death (PCD) distinct from apoptosis, necrosis, and others, has emerged as a key area of interest. However, comprehensive reviews on how natural products influence ferroptosis in respiratory diseases are lacking. This review will explore the therapeutic potential and mechanisms of natural products from TCM in modulating ferroptosis for respiratory diseases like acute lung injury (ALI), asthma, pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), lung ischemia–reperfusion injury (LIRI), pulmonary hypertension (PH), and lung cancer, aiming to provide new insights for research and clinical application in TCM for respiratory health.
pharmacology & pharmacy,integrative & complementary medicine
What problem does this paper attempt to address?
The paper aims to explore the potential and mechanisms of natural products in Traditional Chinese Medicine (TCM) in regulating ferroptosis for the treatment of respiratory diseases. Specifically, the paper focuses on the following points: 1. **Current Status of Respiratory Diseases**: The paper first provides an overview of the global burden of respiratory diseases (such as chronic obstructive pulmonary disease, asthma, pulmonary fibrosis, etc.), emphasizing the health and economic pressures these diseases bring. 2. **Role of Ferroptosis**: Ferroptosis is a unique form of programmed cell death distinct from apoptosis, necrosis, and other forms of cell death. It is closely related to the occurrence and development of various respiratory diseases, including acute lung injury (ALI), chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, etc. 3. **Potential Efficacy of Traditional Chinese Medicine**: Various active ingredients in Traditional Chinese Medicine (such as terpenoids, flavonoids, polysaccharides, etc.) have anti-inflammatory, antioxidant, anti-tumor, and immunomodulatory effects. These components can prevent and treat respiratory diseases by regulating the ferroptosis pathway. 4. **Research Objectives**: This paper reviews the current research progress on how natural products can treat respiratory diseases by regulating ferroptosis and discusses the related signaling pathways, providing new insights into the application of Traditional Chinese Medicine in the field of respiratory health. In summary, this paper attempts to fill the comprehensive research gap on how natural products influence ferroptosis and their role in the treatment of respiratory diseases.